Share price rises
Moderna shares hit a new high on Monday, ending trading up 17% on news of Australia ordering 25 million Moderna vaccines from COVID-19 and recent research showing greater efficacy from the Delta strain of Moderna vaccine than Pfize...
Vaccine for private companies
US authorities are studying the possibility of introducing compulsory vaccination at the federal level. The head of the US Centers for Disease Control and Prevention (CDC), Rochelle Walensky, told Fox News on Friday.
T...
Vaccine certification
British-Swedish pharmaceutical company AstraZeneca will continue to push for certification of its vaccine by the US Food and Drug Administration (FDA). The company's chief executive, Pascal Soriot,...
COVID-19 vaccine
The US administration has purchased a further 200 million doses of coronavirus vaccine from a US company and its German partner BioNTech. This was confirmed by White House press secretary Jennifer ...
Vaccine effectiveness
BioNTech (NASDAQ:BNTX) and Pfizer (NYSE:PFE) shares weakened in Tuesday's premarket as a study in Israel found that in recent weeks their vaccine began to lose effectiveness in preventing the COVID-19 delta strain and the&...
COVID pandemic in the US
US federal authorities are sending medical teams to various parts of the country where new outbreaks of COVID-19 have recently been observed. This was reported by Bloomberg news agency on Thursday, citing administration offi...
Vaccination of Teenagers
Peru's Ministry of Health has authorised the use of a vaccine from the US pharmaceutical company Pfizer against coronavirus to immunise teenagers aged 12 years and older. This was announced on Monday by the head of the minis...
Increase in vaccine production
US company Moderna is building two new production lines, the launch of which will allow it to increase production of coronavirus vaccines by 50%, currently carried...
Vaccine approval application
Novavax will be another major international supplier of vaccines against COVID-19, as trials of its NVX-CoV2373 vaccine have shown an overall effectiveness of 90.4% with good tolerability. Novavax expects coronaviru...
A pandemic in New York City
Most New Yorkers continue to wear masks, despite US President Joe Biden's announcement that it is now OK to be outside without them, and fully vaccinated Americans can take them off even indoors.
A very strict mask regim...
Bayer earnings
The net profit of German chemical and pharmaceutical concern Bayer AG jumped 40% to EUR 2.09 billion in the first quarter, compared to EUR 1.49 billion in the same period of ...
Pfizer's earnings
Pharmaceutical company Pfizer (NYSE:PFE) Inc. increased both net income and revenue by 45% in the first quarter.
According to Pfizer press release, its net income in January-March was $4.88 billion, compared to $3.36 billion&...
Joe Biden's promise
President Joe Biden said on Wednesday that more than 220 million COVID-19 vaccinations have been administered in the US since the start of his presidential term, using the country's three approved coronavirus vaccines.
"After I ...
Vaccination made more accessible to New Yorkers
New York City authorities have expanded access to vaccination against the new coronavirus for the city's entire population, regardless of neighborhood. This was announced on Fr...
Vaccinating Apple employees
Apple Corp. is working with pharmacy company Walgreens Boots Alliance to create a program to vaccinate its employees against coronavirus right in Apple offices. This was reported by Bloomberg on F...
Telemedicine from Amazon
Amazon announced on Wednesday it is expanding its telemedicine service to employees in all 50 US states. The company is also making Amazon Care services available t...
Developing artificial intelligence
Vadim Pinskiy is Vice President of R&D at Nanotronics, where he oversees product development, short-term R&D and long-term development of artificial intelligence platforms. Vadim is interested in applying a...
New drug from COVID-19
Vir Biotechnology (NASDAQ:VIR) shares jumped more than 30% in trading in New York.
Shares rose after the company said its experimental treatment COVID-19, being deve...
Reducing restrictions
New York State is easing restrictions on indoor and outdoor gatherings at the end of March, officials said at a press briefing in Albany.
Beginning March 22, private gathe...
Covid passport introduction
The new Excelsior Pass programme for events is already in pilot mode.
Governor Andrew Cuomo announced Tuesday the rollout of a new pilot program that will require New Yorkers to have some sort of covid pas...
NEW YORK NEWS
News from GlobalNY.biz is the freshest and most relevant information about high-profile events in the region. The task of the resource's news feed is to convey to readers with maximum accuracy and objectivity information about important events in business, politics, economy, healthcare, culture and other spheres of life in New York.
GlobalNY.biz news is a coverage of economic processes taking place in New York, the latest news of public life, incidents and an overview of political events. New York news is information about the activities of small and medium-sized businesses, the work of housing and communal services and utilities, the implementation of significant projects.
The site's journalists describe not only the life of the region, but also talk about the current state of the US economy. Everything you need to know about innovations in the field of industry and agriculture, economy and power is collected in the "News" section at GlobalNY.biz.
New York news quickly informs the reader, shows the real picture and opens up hot topics. Communication with government structures and business enables us to provide our readers with reliable, information-rich material. The main page of the portal contains the key news of New York!
Alena Potapova
Development Director
